Articles published by Regeneron Pharmaceuticals, Inc.
Via GlobeNewswire
Tickers
REGN
Via GlobeNewswire
Tickers
REGN
Via GlobeNewswire
Tickers
REGN
Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis
August 26, 2025
Via GlobeNewswire
Tickers
REGN
Regeneron Announces Investor Conference Presentations
August 07, 2025
Via GlobeNewswire
Tickers
REGN
Via GlobeNewswire
Tickers
REGN
Via GlobeNewswire
Tickers
REGN
Via GlobeNewswire




Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.